Two new papers from/in collaboration with our group

Paper 1:

Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors

Pierre Dillard, Nicholas Casey, Sylvie Pollmann, Patrik Vernhoff, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli & Else Marit Inderberg

Paper 2:

Circulating Tumor Cell Persistence Associates with Long-TermClinical Outcome to a Therapeutic Cancer Vaccine inProstate Cancer

Ingrid Jenny Guldvik, Lina Ekseth, Amar U. Kishan, Andreas Stensvold, Else Marit Inderberg and Wolfgang Lilleby

 

Abstracts:

 

 

 

 

 

 
Jul 4, 2021 Page visits: 35